4-<wbr/>Aminobenzoic Acid hydrazide

4-Aminobenzoic Acid hydrazide

CAT N°: 14845
Price:

From 57.00 48.45

4-Aminobenzoic acid hydrazide (4-ABAH) is an irreversible inhibitor of myeloperoxidase (MPO; IC50 = 0.3 µM).{16906} It reduces the production of hypochlorous acid (HOCl) induced by opsonized zymosan or phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) in isolated human neutrophils with IC50 values of 16 and 2.2 µM, respectively. 4-ABAH inhibits PMA-induced formation of neutrophil extracellular traps (NETs) in the same cells.{61202} It reduces infarct volume and the severity of neurological deficits, as well as increases survival, in a mouse model of cerebral ischemia induced by transient middle cerebral artery occlusion (MCAO) when administered at a dose of 40 mg/kg twice per day.{58284}

Territorial Availability: Available through Bertin Technologies only in France

  • Synonyms
    • 4-amino-benzoic acid, hydrazide
  • Correlated keywords
    • inhibitors inflammation immunology oxidative stress inhibits inhibitions inhibitor-1 one enzymes aminobenzoic acids hydrazide cells cultures in vivo NSCs 640 NSC640 NSC-640 4-aminobenzhydrazide 4-aminoebzoyl aminobenzoylhydrazines amben aminostimil
  • Product Overview:
    4-Aminobenzoic acid hydrazide (4-ABAH) is an irreversible inhibitor of myeloperoxidase (MPO; IC50 = 0.3 µM).{16906} It reduces the production of hypochlorous acid (HOCl) induced by opsonized zymosan or phorbol 12-myristate 13-acetate (PMA; Item No. 10008014) in isolated human neutrophils with IC50 values of 16 and 2.2 µM, respectively. 4-ABAH inhibits PMA-induced formation of neutrophil extracellular traps (NETs) in the same cells.{61202} It reduces infarct volume and the severity of neurological deficits, as well as increases survival, in a mouse model of cerebral ischemia induced by transient middle cerebral artery occlusion (MCAO) when administered at a dose of 40 mg/kg twice per day.{58284}

We also advise you